- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01162148
Pulmonary Rehabilitation and Inspiratory Muscle Training (IMT) for Patients Following Lung Transplantation
Lung transplantation (LT) is now an established treatment option for patients with a wide variety of end-stage lung diseases- aims to improve quality of life and survival. Pulmonary rehabilitation (PR) is widely recognized as an important component of care of patients with chronic obstructive pulmonary disease (COPD), it improves dyspnea, exercise tolerance, quality of life, and reduces healthcare resource utilization.
The goal of pulmonary rehabilitation following lung transplantation is to enhance the physiological and functional benefits resulting from surgery. Inspiratory muscle Training (IMT) is defined as any intervention with the goal of training the inspiratory muscles. IMT can improve inspiratory muscles strength, endurance and exercise capacity in adults with COPD. IMT provides additional benefits to patients undergoing PR program and is worthwhile even in patients who have already undergone a general exercise reconditioning (GER) program. IMT will provide additional benefits (together or without) PR to patients following lung transplantation. No formal guidelines exist regarding the optimal methods of exercise training component of pulmonary rehabilitation for patients recovering from lung transplantation. This study will evaluate the unique influence of IMT in Patients Following Lung Transplantation.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The post lung transplant patients will participate in a rehabilitation program for 6 months. Participants in the proposed study will belong to one of four intervention groups:
- Conventional or regular pulmonary rehabilitation program alone(an exercise program that consist 3 main components: aerobic conditioning, resistance training, and flexibility exercises).
- Very low load IMT(sham IMT) alone.
- Conventional or regular pulmonary rehabilitation program + Targeted inspiratory resistive or threshold IMT.
- Targeted inspiratory resistive or threshold IMT alone.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Petach Tikva, Israel, 49100
- Pulmonary Institute Rabin Medical center, Beilinson Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Post lung transplant patients attending the pulmonary Institute , will be invited to participate,They will be co-operative and able to perform spirometry; and other lung tests.
- Patients will be stable clinically,for at least one month,the patients will be all new to an IMT program.
Exclusion Criteria:
- Patients with cardiac disease,poor compliance,or requirement of supplemental oxygen.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
conventional
|
Conventional or regular pulmonary rehabilitation program alone
|
Experimental: 2
sham IMT
|
very low load IMT (sham IMT) alone
|
Experimental: 3
Conventional plus threshold IMT
|
Conventional or regular pulmonary rehabilitation program + targeted inspiratory resistive or threshold IMT
|
Experimental: 4
threshold IMT alone
|
Targeted inspiratory resistive or threshold IMT alone
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
maximal exercise capacity
Time Frame: 9 months after starting interventions
|
at 9 months after starting interventions
|
9 months after starting interventions
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lung function (FEV1, FVC)
Time Frame: 9 months after starting interventions
|
9 months after starting interventions
|
9 months after starting interventions
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mordechai R Kramer, MD, Rabin Medical center, Beilinson Hospital Petach Tikva, 49100 Israel
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- rab581710ctil
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Transplantation
-
Astellas Pharma Europe Ltd.Active, not recruitingLiver Transplantation | Kidney Transplantation | Heart Transplantation | Lung Transplantation | Intestine TransplantationBelgium, Czechia, France, Germany, Italy, Poland, United Kingdom
-
Emory UniversityCompletedLiver Transplantation | Kidney Transplantation | Heart Transplantation | Lung Transplantation | Heart-Lung TransplantationUnited States
-
Astellas Pharma IncCompletedHeart Transplantation | Lung Transplantation | Pancreas (Including SPK) TransplantationFrance, United Kingdom, Taiwan, Belgium, Italy, Austria
-
Hannover Medical SchoolUnknownExercise Training | Lung Transplantation | Psychotherapy | Heart-Lung Transplantation | "Rehabilitation"Germany
-
University of AlbertaNatera, Inc.; One LambdaRecruiting
-
Universidad Complutense de MadridHospital Universitario 12 de OctubreRecruiting
-
KU LeuvenCompleted
-
Hopital FochCompleted
-
Emory UniversityTerminated
-
Hannover Medical SchoolCorscience, Inc.CompletedLung TransplantationGermany
Clinical Trials on Conventional or regular pulmonary rehabilitation program alone
-
University of Nove de JulhoInCor Heart InstituteCompleted
-
Blue Marble Rehab IncWake Forest University Health SciencesCompleted
-
Alexandria UniversityCompleted
-
Fundación Pública Andaluza para la gestión de la...Unknown
-
The Opole University of TechnologyRecruiting
-
Alexandria UniversityMohamed Wahid Elsayed Elsayed; Prof. Dr. Tamer Abdullah Helmy; Dr. Osama Saeed...UnknownPulmonary Rehabilitation | Stroke, Acute | MoralityEgypt
-
University Hospital, LilleTerminated
-
Bispebjerg HospitalDanish Lung Association; Sygekassernes Helsefond; Ministry of the Interior and...CompletedChronic Obstructive Pulmonary Disease
-
Dartmouth-Hitchcock Medical CenterAmerican Academy of Medical AcupunctureRecruiting
-
Schön Klinik Berchtesgadener LandLungenfibrose e.V.TerminatedIdiopathic Pulmonary Fibrosis and COPDGermany